Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahua Dey

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumorsDerek A Wainwright, Alan L Chang, Mahua Dey, et al.
Cancer Medicine|October 25, 2013
Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomasIlya Ulasov, Bart Thaci, Purvaba Sarvaiya, et al.
Stem Cell Reports|September 6, 2016
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of GliomaMahua Dey, Dou Yu, Deepak Kanojia, et al.
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Immunohorizons|June 9, 2021
Aging- and Tumor-Mediated Increase in CD8<sup>+</sup>CD28<sup>-</sup> T Cells Might Impose a Strong Barrier to Success of Immunotherapy in GlioblastomaWei X Huff, Marpe Bam, Jack M Shireman, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapyLijie Zhai, Mahua Dey, Kristen L Lauing, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Neurosurgery|January 31, 2015
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trialMahua Dey, Agnieszka Stadnik, Fady Riad, et al.
Cancer Research|August 18, 2016
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor CellsAlan L Chang, Jason Miska, Derek A Wainwright, et al.
Neuro-Oncology|May 4, 2026
Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapyLei Zhao, Paul A Clark, Jack M Shireman, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumorsDerek A Wainwright, Alan L Chang, Mahua Dey, et al.
Cancer Medicine|October 25, 2013
Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomasIlya Ulasov, Bart Thaci, Purvaba Sarvaiya, et al.
Stem Cell Reports|September 6, 2016
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of GliomaMahua Dey, Dou Yu, Deepak Kanojia, et al.
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Immunohorizons|June 9, 2021
Aging- and Tumor-Mediated Increase in CD8<sup>+</sup>CD28<sup>-</sup> T Cells Might Impose a Strong Barrier to Success of Immunotherapy in GlioblastomaWei X Huff, Marpe Bam, Jack M Shireman, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapyLijie Zhai, Mahua Dey, Kristen L Lauing, et al.
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
Neurosurgery|January 31, 2015
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trialMahua Dey, Agnieszka Stadnik, Fady Riad, et al.
Cancer Research|August 18, 2016
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor CellsAlan L Chang, Jason Miska, Derek A Wainwright, et al.
Neuro-Oncology|May 4, 2026
Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapyLei Zhao, Paul A Clark, Jack M Shireman, et al.
Pageof 8